Hemianopsia

Partial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.

Also Known As:

Bitemporal Hemianopsia; Binasal Hemianopsia; Homonymous Hemianopsia; Bitemporal Hemianopia; Quadrantanopia; Altidudinal Hemianopia; Altitudinal Hemianopsia; Binasal Hemianopia; Hemianopia; Homonymous Hemianopia; Altidudinal Hemianopias; Altitudinal Hemianopsias; Binasal Hemianopias; Binasal Hemianopsias; Bitemporal Hemianopias; Bitemporal Hemianopsias; Hemianopia, Altidudinal; Hemianopia, Binasal; Hemianopia, Bitemporal; Hemianopia, Homonymous; Hemianopias; Hemianopias, Altidudinal; Hemianopias, Binasal; Hemianopias, Bitemporal; Hemianopias, Homonymous; Hemianopsia, Altitudinal; Hemianopsias; Hemianopsias, Altitudinal; Hemianopsias, Binasal; Hemianopsias, Bitemporal; Hemianopsias, Homonymous; Homonymous Hemianopias; Homonymous Hemianopsias; Quadrantanopias; Quadrantanopsias; Hemianopsia, Binasal; Hemianopsia, Bitemporal; Hemianopsia, Homonymous; Quadrantanopsia

Nervous System Diseases: 14178
- Neurologic Manifestations: 7102
  - Sensation Disorders: 117
    - Vision Disorders: 2977
      - Hemianopsia: 398
Eye Diseases: 3522
- Vision Disorders: 2977
  - Blindness: 5548
    - Hemianopsia: 398
Signs and Symptoms Pathological Conditions
- Signs and Symptoms
  - Neurologic Manifestations: 7102
    - Sensation Disorders: 117
      - Vision Disorders: 2977
        Hemianopsia: 398

Martin Vasquez Selected Research

Martin Vasquez Research Topics

Disease

Drug/Important Bio-Agent (IBA)